Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics (PK)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
Co-Hosted with Bioanalysis Zone
What is particular to the immunogenicity of gene therapies as compared to other biologic drugs? Which immunogenicity assessments are recommended from the scientific point of view? BioAgilytix’s experts Dr. Arno Kromminga and Dr. Lydia Michaut address these questions and more.
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
LinkedIn Company Updates
3 Days Agoview on linkedin
Last month at WRIB, our scientific team had the opportunity to participate in a number of discussions surrounding the latest topics of interest in biomarkers, immunogenicity, and regulatory standards. We wanted to share some of the event takeaways we found most interesting and valuable: https://lnkd.in/epsns3U
3 Days Agoview on linkedin
Do you have a problematic assay other CROs can’t crack? Speak with one of our scientists today and learn how we’ll take on your rescue project to get it back on track, fast and with accurate results: https://lnkd.in/gX9rnxR
4 Days Agoview on linkedin
The FDA recently published a guidance to help sponsors demonstrate that a proposed therapeutic protein product is interchangeable with a reference product, discussing the type and amount of data needed to support interchangeability. Do you know what these considerations entail? Read BioPharm International for more: https://lnkd.in/eB9x4Hv
May 17, 2019Key Takeaways from the 13th Annual WRIB, 2019
May 15, 2019Podcast Feature: Enabling the Breakthroughs of Tomorrow, Today
March 26, 2019BioAgilytix Announces Promotion of Corinna Fiorotti, Ph.D. to Scientific Officer and Key Accounts Director
February 7, 2019BioAgilytix Welcomes Lydia Michaut, Ph.D. to Team as Scientific Officer
May 9, 2018Evaluating the Immunogenicity of Antibody–drug Conjugates
April 16, 2018Strategies for Development and Validation of Neutralizing Antibody Assays Supporting Biosimilars
Services
Platforms
Choose a Location to learn more about the premier bioanalytical services and solutions available at each of our advanced laboratories in the USA and Europe.
